Research Article

Diabetes Mellitus Type 2 Patients with Abdominal Obesity Are Prone to Osteodysfunction: A Cross-Sectional Study

Table 2

Correlation of abdominal obesity index and BTMs.
(a) Multiple linear regression analysis of abdominal obesity index and BTMs (male)

BTMsIndex
β-CTXOCP1NP
Β (95% CI)Β (95% CI)Β (95% CI)

BMI-.008 (-.014, -.002)0.006-.009 (-.014, -.004)<0.0010.001 (-.004, 0.006)0.643
NC-.004 (-.010, 0.003)0.258-.007 (-.012, -.002)0.0050.003 (-.002, 0.009)0.252
WC-.004 (-.006, -.002)<0.001-.005 (-.007, -.003)<0.0010.001 (-.001, 0.003)0.265
HC-.001 (-.004, 0.002)0.522-.002 (-.004, 0.000)0.1110.001 (-.001, 0.004)0.396
VAI-.004 (-0.09, 0.002)0.172-.001 (-.005, 0.003)0.686-.002 (-.006, 0.003)0.492
LAP0.000 (-0.001, 0.000)0.0250.000 (0.000, 0.000)0.1880.000 (0.000, 0.000)0.723
WHR-1.055 (-1.430, -.681)<0.001-1.137 (-1.442, -.832)<0.0010.126 (-.204, 0.457)0.454
CVAI-.001 (-.001, 0.000)0.001-.001 (-.001, -.001)<0.0010.000 (0.000, 0.001)0.183

(b) Multiple linear regression analysis of abdominal obesity index and BTMs (female)

BTMsIndex
β-CTXOCP1NP
Β (95% CI)Β (95% CI)Β (95% CI)

BMI-.014 (-.019, -.009)<0.001-.014 (-.018, -.010)<0.001-.001 (-.005, 0.004)0.741
NC-.012 (-.019, -.006)<0.001-.014 (-.019, -.009)<0.001-.001 (-.007, 0.004)0.675
WC-.005 (-.007, -.003)<0.001-.004 (-.006, -.003)<0.001-.001 (-.002, 0.001)0.481
HC-.005 (-.007, -.003)<0.001-.004 (-.006, -.002)<0.0010.000 (-.002, 0.002)0.849
VAI0.018 (0.000, 0.036)0.0440.014 (-.001, 0.029)0.0610.021 (0.005, 0.037)0.010
LAP-.002 (-.002, -.001)<0.001-.001 (-.002, -.001)<0.0010.000 (-.001, 0.001)0.921
WHR-.296 (-.563, -.028)0.030-.296 (-.516, -.075)0.009-.171 (-.407, 0.065)0.156
CVAI-.002 (-.003, -.001)<0.001-.002 (-.003, -.001)<0.0010.000 (-.001, 0.000)0.345

The model was adjusted for age, TC, TG, HDL, LDL, FPG, HbA1c, glucagon, C-peptide, insulin, VitD, current smoking, and hypertension. The concentrations of BTMs were naturally logarithmically transformed to follow an approximately normal distribution. The abbreviations were the same with Table 1.